Influence of Fractionation and Beam Sequencing on Absorbed Dose to Circulating Lymphocytes During Ultra-High Dose Rate and Conventional Radiotherapy: An In Silico Study
JCO Clinical Cancer Informatics · 2026-07 · 10 (3)
DOI: 10.1200/cci-26-00091 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Clinical Cancer Informatics, 2026-07. Verfasst von François de Kermenguy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Inserm U1030 Radiothérapie Moléculaire et Innovation Thérapeutique, Gustave Roussy, Université Paris-Saclay, Villejuif, France. Hauptthemen laut MEDLINE: Lymphocytes, Dose Fractionation, Radiation, Brain Neoplasms, Radiotherapy, Conformal. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PURPOSE Several in silico models concluded that ultra-high dose rate (UHDR) radiotherapy could spare large quantities of circulating lymphocytes. However, preclinical studies failed to show a reduction in radiation-induced lymphopenia after UHDR irradiation compared with conventional dose rates (CONV). This study aims to investigate the influence of fractionation and beam sequencing on absorbed dose to circulating lymphocytes during CONV and UHDR irradiations. MATERIALS AND METHODS The LymphoDose framework was applied to a cohort of 162 patients treated for brain tumors with 3D conformal radiotherapy. Four scenarios of UHDR treatment were compared: (S1) one fraction with all beams delivered simultaneously, (S2) one fraction with sequentially delivered beams, (S3) three fractions with all beams delivered simultaneously, and (S4) three fractions with sequentially delivered beams. RESULTS UHDR fractionation and the beam delivery scheme had a significant impact on irradiated blood volume (1.3% ± 0.1% for S1 v 13% ± 3.2% for S4) and lymphocyte pool (12.5% ± 0.1% for S1 v 32.8% ± 0.2% for S4). UHDR scenarios primarily irradiate lymphocytes through exposure of head-and-neck lymph node rather than circulating blood. CONV and UHDR result in distinct temporal dose patterns for lymphocytes, characterized by either numerous low-dose fractions or a few high-dose pulses. CONCLUSION The doses delivered to lymphoid organs account for a substantial portion of the total dose received by the lymphocyte pool, showing only a limited difference between UHDR and CONV in terms of lymphocyte exposure. The fractionation strategy of UHDR irradiation beams could play an important role in successfully translating UHDR treatments into clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Inserm U1030 Radiothérapie Moléculaire et Innovation Thérapeutique, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
- Department of Radiation Oncology, Mass General Brigham Cancer Institute and Harvard Medical School, Boston, MA.
- Département de radiothérapie, Gustave Roussy, Villejuif, France.
ORCID-Profile: François de Kermenguy, Camilla Satragno, Mohammed El-Aichi, Ibrahima Diallo, Cristina Veres, Cathyanne Schott, Charlotte Robert
Zitieren
APA
de Kermenguy, F., Satragno, C., El-Aichi, M., Diallo, I., Veres, C., Talebi, F., Schott, C., Deutsch, E., & Robert, C. (2026). Influence of Fractionation and Beam Sequencing on Absorbed Dose to Circulating Lymphocytes During Ultra-High Dose Rate and Conventional Radiotherapy: An In Silico Study. JCO Clinical Cancer Informatics, 10(3). https://doi.org/10.1200/cci-26-00091
Vancouver
de Kermenguy F, Satragno C, El-Aichi M, Diallo I, Veres C, Talebi F, et al. Influence of Fractionation and Beam Sequencing on Absorbed Dose to Circulating Lymphocytes During Ultra-High Dose Rate and Conventional Radiotherapy: An In Silico Study. JCO Clinical Cancer Informatics. 2026;10(3). doi:10.1200/cci-26-00091
BibTeX
@article{deKermenguy2026,
author = {de Kermenguy, François and Satragno, Camilla and El-Aichi, Mohammed and Diallo, Ibrahima and Veres, Cristina and Talebi, Fereshteh and Schott, Cathyanne and Deutsch, Eric and Robert, Charlotte},
title = {Influence of Fractionation and Beam Sequencing on Absorbed Dose to Circulating Lymphocytes During Ultra-High Dose Rate and Conventional Radiotherapy: An In Silico Study},
journal = {JCO Clinical Cancer Informatics},
year = {2026},
volume = {10},
number = {3},
doi = {10.1200/cci-26-00091}
}
EUVIMED